nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—NR1I2—Docetaxel—skin cancer	0.258	0.353	CbGbCtD
Ethinyl Estradiol—CYP2C8—Vismodegib—skin cancer	0.092	0.126	CbGbCtD
Ethinyl Estradiol—ABCB1—Vismodegib—skin cancer	0.0623	0.0852	CbGbCtD
Ethinyl Estradiol—CYP3A4—Temozolomide—skin cancer	0.0538	0.0736	CbGbCtD
Ethinyl Estradiol—CYP3A4—Imiquimod—skin cancer	0.0538	0.0736	CbGbCtD
Ethinyl Estradiol—ABCC2—Docetaxel—skin cancer	0.0518	0.0709	CbGbCtD
Ethinyl Estradiol—CYP3A4—Vismodegib—skin cancer	0.0373	0.051	CbGbCtD
Ethinyl Estradiol—ABCB1—Dactinomycin—skin cancer	0.0327	0.0447	CbGbCtD
Ethinyl Estradiol—CYP2C8—Fluorouracil—skin cancer	0.0327	0.0447	CbGbCtD
Ethinyl Estradiol—CYP3A4—Vemurafenib—skin cancer	0.0295	0.0403	CbGbCtD
Ethinyl Estradiol—ABCB1—Docetaxel—skin cancer	0.0169	0.0231	CbGbCtD
Ethinyl Estradiol—CYP3A4—Docetaxel—skin cancer	0.0101	0.0138	CbGbCtD
Ethinyl Estradiol—SHBG—hindlimb—skin cancer	0.00441	0.134	CbGeAlD
Ethinyl Estradiol—NR1I2—head—skin cancer	0.00196	0.0595	CbGeAlD
Ethinyl Estradiol—ESR2—neck—skin cancer	0.00155	0.0471	CbGeAlD
Ethinyl Estradiol—AOX1—nipple—skin cancer	0.00151	0.0458	CbGeAlD
Ethinyl Estradiol—SHBG—neck—skin cancer	0.00151	0.0457	CbGeAlD
Ethinyl Estradiol—ESR1—blood vessel—skin cancer	0.00148	0.0451	CbGeAlD
Ethinyl Estradiol—SLC10A1—female reproductive system—skin cancer	0.00117	0.0356	CbGeAlD
Ethinyl Estradiol—ESR2—connective tissue—skin cancer	0.00111	0.0337	CbGeAlD
Ethinyl Estradiol—SHBG—connective tissue—skin cancer	0.00108	0.0328	CbGeAlD
Ethinyl Estradiol—ESR1—neck—skin cancer	0.00106	0.0322	CbGeAlD
Ethinyl Estradiol—ESR2—epithelium—skin cancer	0.00105	0.032	CbGeAlD
Ethinyl Estradiol—SLC10A1—head—skin cancer	0.000979	0.0297	CbGeAlD
Ethinyl Estradiol—AOX1—mammalian vulva—skin cancer	0.00088	0.0267	CbGeAlD
Ethinyl Estradiol—ESR2—lymphoid tissue—skin cancer	0.000812	0.0247	CbGeAlD
Ethinyl Estradiol—ESR2—female reproductive system—skin cancer	0.000783	0.0238	CbGeAlD
Ethinyl Estradiol—SHBG—female reproductive system—skin cancer	0.000761	0.0231	CbGeAlD
Ethinyl Estradiol—ESR1—connective tissue—skin cancer	0.000761	0.0231	CbGeAlD
Ethinyl Estradiol—AOX1—female reproductive system—skin cancer	0.000754	0.0229	CbGeAlD
Ethinyl Estradiol—ESR1—epithelium—skin cancer	0.000722	0.0219	CbGeAlD
Ethinyl Estradiol—Immune system disorder—Imiquimod—skin cancer	0.000699	0.00296	CcSEcCtD
Ethinyl Estradiol—Amenorrhoea—Docetaxel—skin cancer	0.000699	0.00296	CcSEcCtD
Ethinyl Estradiol—Cough—Vemurafenib—skin cancer	0.000689	0.00292	CcSEcCtD
Ethinyl Estradiol—Alopecia—Imiquimod—skin cancer	0.000684	0.0029	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Imiquimod—skin cancer	0.000678	0.00287	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Imiquimod—skin cancer	0.000674	0.00285	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000668	0.00283	CcSEcCtD
Ethinyl Estradiol—Vomiting—Vismodegib—skin cancer	0.000663	0.00281	CcSEcCtD
Ethinyl Estradiol—Affect lability—Temozolomide—skin cancer	0.00066	0.00279	CcSEcCtD
Ethinyl Estradiol—Rash—Vismodegib—skin cancer	0.000658	0.00279	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Vismodegib—skin cancer	0.000657	0.00278	CcSEcCtD
Ethinyl Estradiol—ESR2—head—skin cancer	0.000654	0.0199	CbGeAlD
Ethinyl Estradiol—Back pain—Imiquimod—skin cancer	0.000652	0.00276	CcSEcCtD
Ethinyl Estradiol—Infection—Vemurafenib—skin cancer	0.00064	0.00271	CcSEcCtD
Ethinyl Estradiol—Mood swings—Temozolomide—skin cancer	0.000635	0.00269	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Vemurafenib—skin cancer	0.000632	0.00268	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Vemurafenib—skin cancer	0.000626	0.00265	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Imiquimod—skin cancer	0.000625	0.00265	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Bleomycin—skin cancer	0.000621	0.00263	CcSEcCtD
Ethinyl Estradiol—Nausea—Vismodegib—skin cancer	0.00062	0.00263	CcSEcCtD
Ethinyl Estradiol—Angioedema—Imiquimod—skin cancer	0.000616	0.00261	CcSEcCtD
Ethinyl Estradiol—Blood pressure increased—Docetaxel—skin cancer	0.000614	0.0026	CcSEcCtD
Ethinyl Estradiol—Malaise—Imiquimod—skin cancer	0.000607	0.00257	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Temozolomide—skin cancer	0.000606	0.00257	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Bleomycin—skin cancer	0.000604	0.00256	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Bleomycin—skin cancer	0.0006	0.00254	CcSEcCtD
Ethinyl Estradiol—Influenza like illness—Docetaxel—skin cancer	0.000596	0.00253	CcSEcCtD
Ethinyl Estradiol—Irritability—Fluorouracil—skin cancer	0.00059	0.0025	CcSEcCtD
Ethinyl Estradiol—ABCC2—female reproductive system—skin cancer	0.000589	0.0179	CbGeAlD
Ethinyl Estradiol—Cough—Imiquimod—skin cancer	0.000588	0.00249	CcSEcCtD
Ethinyl Estradiol—ABCB1—blood vessel—skin cancer	0.000586	0.0178	CbGeAlD
Ethinyl Estradiol—Abdominal distension—Temozolomide—skin cancer	0.000583	0.00247	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Docetaxel—skin cancer	0.000583	0.00247	CcSEcCtD
Ethinyl Estradiol—Anxiety—Imiquimod—skin cancer	0.000572	0.00242	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00057	0.00241	CcSEcCtD
Ethinyl Estradiol—Discomfort—Imiquimod—skin cancer	0.000567	0.0024	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Temozolomide—skin cancer	0.000557	0.00236	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000557	0.00236	CcSEcCtD
Ethinyl Estradiol—ESR1—lymphoid tissue—skin cancer	0.000556	0.0169	CbGeAlD
Ethinyl Estradiol—Fatigue—Vemurafenib—skin cancer	0.000556	0.00235	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Docetaxel—skin cancer	0.000555	0.00235	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Bleomycin—skin cancer	0.000553	0.00234	CcSEcCtD
Ethinyl Estradiol—Constipation—Vemurafenib—skin cancer	0.000551	0.00234	CcSEcCtD
Ethinyl Estradiol—Oedema—Imiquimod—skin cancer	0.00055	0.00233	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Bleomycin—skin cancer	0.00055	0.00233	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Bleomycin—skin cancer	0.000547	0.00232	CcSEcCtD
Ethinyl Estradiol—Infection—Imiquimod—skin cancer	0.000546	0.00231	CcSEcCtD
Ethinyl Estradiol—Dysuria—Temozolomide—skin cancer	0.000542	0.00229	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Imiquimod—skin cancer	0.000539	0.00228	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Temozolomide—skin cancer	0.000538	0.00228	CcSEcCtD
Ethinyl Estradiol—ESR1—female reproductive system—skin cancer	0.000536	0.0163	CbGeAlD
Ethinyl Estradiol—Pollakiuria—Temozolomide—skin cancer	0.000535	0.00227	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Imiquimod—skin cancer	0.000534	0.00226	CcSEcCtD
Ethinyl Estradiol—Weight increased—Temozolomide—skin cancer	0.000527	0.00223	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Temozolomide—skin cancer	0.000524	0.00222	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Temozolomide—skin cancer	0.000517	0.00219	CcSEcCtD
Ethinyl Estradiol—Infestation—Temozolomide—skin cancer	0.000517	0.00219	CcSEcCtD
Ethinyl Estradiol—Depression—Temozolomide—skin cancer	0.000515	0.00218	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Vemurafenib—skin cancer	0.00051	0.00216	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Dactinomycin—skin cancer	0.000509	0.00216	CcSEcCtD
Ethinyl Estradiol—CYP2B6—skin of body—skin cancer	0.000508	0.0154	CbGeAlD
Ethinyl Estradiol—Neuropathy peripheral—Temozolomide—skin cancer	0.000506	0.00214	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Temozolomide—skin cancer	0.000502	0.00213	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000496	0.0021	CcSEcCtD
Ethinyl Estradiol—Alopecia—Bleomycin—skin cancer	0.000486	0.00206	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Dactinomycin—skin cancer	0.000485	0.00205	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Temozolomide—skin cancer	0.000485	0.00205	CcSEcCtD
Ethinyl Estradiol—Hot flush—Docetaxel—skin cancer	0.000477	0.00202	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Fluorouracil—skin cancer	0.000476	0.00202	CcSEcCtD
Ethinyl Estradiol—Infestation—Fluorouracil—skin cancer	0.000476	0.00202	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Vemurafenib—skin cancer	0.000475	0.00201	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Imiquimod—skin cancer	0.000475	0.00201	CcSEcCtD
Ethinyl Estradiol—Fatigue—Imiquimod—skin cancer	0.000474	0.00201	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Docetaxel—skin cancer	0.000472	0.002	CcSEcCtD
Ethinyl Estradiol—Visual disturbance—Docetaxel—skin cancer	0.00047	0.00199	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Fluorouracil—skin cancer	0.000469	0.00199	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Fluorouracil—skin cancer	0.000467	0.00198	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Fluorouracil—skin cancer	0.000467	0.00198	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Temozolomide—skin cancer	0.000466	0.00197	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Temozolomide—skin cancer	0.000464	0.00196	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Fluorouracil—skin cancer	0.000463	0.00196	CcSEcCtD
Ethinyl Estradiol—Asthenia—Vemurafenib—skin cancer	0.000463	0.00196	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Temozolomide—skin cancer	0.000461	0.00195	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Temozolomide—skin cancer	0.00046	0.00195	CcSEcCtD
Ethinyl Estradiol—ESR2—lymph node—skin cancer	0.000458	0.0139	CbGeAlD
Ethinyl Estradiol—Urinary tract disorder—Temozolomide—skin cancer	0.000458	0.00194	CcSEcCtD
Ethinyl Estradiol—Pruritus—Vemurafenib—skin cancer	0.000456	0.00193	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Temozolomide—skin cancer	0.000456	0.00193	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Temozolomide—skin cancer	0.000455	0.00193	CcSEcCtD
Ethinyl Estradiol—Alopecia—Dactinomycin—skin cancer	0.000453	0.00192	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Imiquimod—skin cancer	0.000453	0.00192	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Imiquimod—skin cancer	0.00045	0.0019	CcSEcCtD
Ethinyl Estradiol—ESR1—head—skin cancer	0.000448	0.0136	CbGeAlD
Ethinyl Estradiol—Visual impairment—Temozolomide—skin cancer	0.000447	0.00189	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Fluorouracil—skin cancer	0.000447	0.00189	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Docetaxel—skin cancer	0.000446	0.00189	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Bleomycin—skin cancer	0.000444	0.00188	CcSEcCtD
Ethinyl Estradiol—CYP2C8—female reproductive system—skin cancer	0.000442	0.0134	CbGeAlD
Ethinyl Estradiol—Diarrhoea—Vemurafenib—skin cancer	0.000441	0.00187	CcSEcCtD
Ethinyl Estradiol—AOX1—lymph node—skin cancer	0.000441	0.0134	CbGeAlD
Ethinyl Estradiol—Migraine—Docetaxel—skin cancer	0.000439	0.00186	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Temozolomide—skin cancer	0.000438	0.00186	CcSEcCtD
Ethinyl Estradiol—Urticaria—Imiquimod—skin cancer	0.000437	0.00185	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Imiquimod—skin cancer	0.000435	0.00184	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Imiquimod—skin cancer	0.000435	0.00184	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Temozolomide—skin cancer	0.000433	0.00184	CcSEcCtD
Ethinyl Estradiol—Malaise—Bleomycin—skin cancer	0.000432	0.00183	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Fluorouracil—skin cancer	0.000429	0.00182	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Fluorouracil—skin cancer	0.000428	0.00181	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Fluorouracil—skin cancer	0.000427	0.00181	CcSEcCtD
Ethinyl Estradiol—Dizziness—Vemurafenib—skin cancer	0.000426	0.00181	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Fluorouracil—skin cancer	0.000425	0.0018	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Fluorouracil—skin cancer	0.000424	0.0018	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Temozolomide—skin cancer	0.000421	0.00178	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Temozolomide—skin cancer	0.000419	0.00177	CcSEcCtD
Ethinyl Estradiol—Cough—Bleomycin—skin cancer	0.000418	0.00177	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Dactinomycin—skin cancer	0.000414	0.00175	CcSEcCtD
Ethinyl Estradiol—CYP2B6—lymphoid tissue—skin cancer	0.000411	0.0125	CbGeAlD
Ethinyl Estradiol—Vomiting—Vemurafenib—skin cancer	0.00041	0.00174	CcSEcCtD
Ethinyl Estradiol—Alopecia—Temozolomide—skin cancer	0.00041	0.00174	CcSEcCtD
Ethinyl Estradiol—Rash—Vemurafenib—skin cancer	0.000406	0.00172	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Temozolomide—skin cancer	0.000406	0.00172	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Vemurafenib—skin cancer	0.000406	0.00172	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Imiquimod—skin cancer	0.000405	0.00172	CcSEcCtD
Ethinyl Estradiol—Headache—Vemurafenib—skin cancer	0.000404	0.00171	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Temozolomide—skin cancer	0.000404	0.00171	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Docetaxel—skin cancer	0.000403	0.00171	CcSEcCtD
Ethinyl Estradiol—Discomfort—Bleomycin—skin cancer	0.000403	0.00171	CcSEcCtD
Ethinyl Estradiol—Malaise—Dactinomycin—skin cancer	0.000402	0.0017	CcSEcCtD
Ethinyl Estradiol—CYP2B6—female reproductive system—skin cancer	0.000396	0.012	CbGeAlD
Ethinyl Estradiol—Asthenia—Imiquimod—skin cancer	0.000394	0.00167	CcSEcCtD
Ethinyl Estradiol—Oedema—Bleomycin—skin cancer	0.000391	0.00165	CcSEcCtD
Ethinyl Estradiol—Back pain—Temozolomide—skin cancer	0.00039	0.00165	CcSEcCtD
Ethinyl Estradiol—Pruritus—Imiquimod—skin cancer	0.000389	0.00165	CcSEcCtD
Ethinyl Estradiol—Infection—Bleomycin—skin cancer	0.000388	0.00164	CcSEcCtD
Ethinyl Estradiol—Nausea—Vemurafenib—skin cancer	0.000383	0.00162	CcSEcCtD
Ethinyl Estradiol—Alopecia—Fluorouracil—skin cancer	0.000378	0.0016	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Imiquimod—skin cancer	0.000376	0.00159	CcSEcCtD
Ethinyl Estradiol—Discomfort—Dactinomycin—skin cancer	0.000375	0.00159	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Temozolomide—skin cancer	0.000375	0.00159	CcSEcCtD
Ethinyl Estradiol—Angioedema—Temozolomide—skin cancer	0.000369	0.00156	CcSEcCtD
Ethinyl Estradiol—Oedema—Dactinomycin—skin cancer	0.000364	0.00154	CcSEcCtD
Ethinyl Estradiol—Malaise—Temozolomide—skin cancer	0.000364	0.00154	CcSEcCtD
Ethinyl Estradiol—Dizziness—Imiquimod—skin cancer	0.000364	0.00154	CcSEcCtD
Ethinyl Estradiol—Infection—Dactinomycin—skin cancer	0.000362	0.00153	CcSEcCtD
Ethinyl Estradiol—Cough—Temozolomide—skin cancer	0.000352	0.00149	CcSEcCtD
Ethinyl Estradiol—Weight increased—Docetaxel—skin cancer	0.000351	0.00149	CcSEcCtD
Ethinyl Estradiol—Vomiting—Imiquimod—skin cancer	0.00035	0.00148	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Docetaxel—skin cancer	0.000349	0.00148	CcSEcCtD
Ethinyl Estradiol—Rash—Imiquimod—skin cancer	0.000347	0.00147	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Imiquimod—skin cancer	0.000346	0.00147	CcSEcCtD
Ethinyl Estradiol—ABCC2—lymph node—skin cancer	0.000345	0.0105	CbGeAlD
Ethinyl Estradiol—Headache—Imiquimod—skin cancer	0.000344	0.00146	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Docetaxel—skin cancer	0.000344	0.00146	CcSEcCtD
Ethinyl Estradiol—Infestation—Docetaxel—skin cancer	0.000344	0.00146	CcSEcCtD
Ethinyl Estradiol—Anxiety—Temozolomide—skin cancer	0.000342	0.00145	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000341	0.00145	CcSEcCtD
Ethinyl Estradiol—Discomfort—Temozolomide—skin cancer	0.00034	0.00144	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Docetaxel—skin cancer	0.000339	0.00143	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Docetaxel—skin cancer	0.000337	0.00143	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Docetaxel—skin cancer	0.000337	0.00143	CcSEcCtD
Ethinyl Estradiol—CYP2B6—head—skin cancer	0.000331	0.0101	CbGeAlD
Ethinyl Estradiol—Oedema—Temozolomide—skin cancer	0.000329	0.0014	CcSEcCtD
Ethinyl Estradiol—Infection—Temozolomide—skin cancer	0.000327	0.00139	CcSEcCtD
Ethinyl Estradiol—Nausea—Imiquimod—skin cancer	0.000327	0.00138	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Temozolomide—skin cancer	0.000323	0.00137	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Bleomycin—skin cancer	0.000322	0.00136	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Temozolomide—skin cancer	0.00032	0.00136	CcSEcCtD
Ethinyl Estradiol—Fatigue—Dactinomycin—skin cancer	0.000314	0.00133	CcSEcCtD
Ethinyl Estradiol—ESR1—lymph node—skin cancer	0.000314	0.00953	CbGeAlD
Ethinyl Estradiol—Discomfort—Fluorouracil—skin cancer	0.000313	0.00133	CcSEcCtD
Ethinyl Estradiol—Urticaria—Bleomycin—skin cancer	0.00031	0.00131	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Docetaxel—skin cancer	0.00031	0.00131	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Docetaxel—skin cancer	0.000309	0.00131	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Bleomycin—skin cancer	0.000309	0.00131	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Docetaxel—skin cancer	0.000308	0.00131	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Docetaxel—skin cancer	0.000307	0.0013	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Docetaxel—skin cancer	0.000306	0.0013	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Docetaxel—skin cancer	0.000305	0.00129	CcSEcCtD
Ethinyl Estradiol—Oedema—Fluorouracil—skin cancer	0.000304	0.00129	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Docetaxel—skin cancer	0.000303	0.00128	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Docetaxel—skin cancer	0.000302	0.00128	CcSEcCtD
Ethinyl Estradiol—Infection—Fluorouracil—skin cancer	0.000302	0.00128	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Dactinomycin—skin cancer	0.0003	0.00127	CcSEcCtD
Ethinyl Estradiol—CYP3A4—female reproductive system—skin cancer	0.000299	0.00909	CbGeAlD
Ethinyl Estradiol—Gastrointestinal pain—Dactinomycin—skin cancer	0.000298	0.00126	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Fluorouracil—skin cancer	0.000298	0.00126	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Docetaxel—skin cancer	0.000297	0.00126	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Docetaxel—skin cancer	0.000292	0.00124	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Docetaxel—skin cancer	0.000288	0.00122	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Dactinomycin—skin cancer	0.000288	0.00122	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Dactinomycin—skin cancer	0.000288	0.00122	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Bleomycin—skin cancer	0.000288	0.00122	CcSEcCtD
Ethinyl Estradiol—ABCB1—epithelium—skin cancer	0.000285	0.00866	CbGeAlD
Ethinyl Estradiol—Gastrointestinal disorder—Temozolomide—skin cancer	0.000284	0.0012	CcSEcCtD
Ethinyl Estradiol—Fatigue—Temozolomide—skin cancer	0.000284	0.0012	CcSEcCtD
Ethinyl Estradiol—Constipation—Temozolomide—skin cancer	0.000282	0.00119	CcSEcCtD
Ethinyl Estradiol—Asthenia—Bleomycin—skin cancer	0.00028	0.00119	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Docetaxel—skin cancer	0.00028	0.00119	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Docetaxel—skin cancer	0.000279	0.00118	CcSEcCtD
Ethinyl Estradiol—Pruritus—Bleomycin—skin cancer	0.000276	0.00117	CcSEcCtD
Ethinyl Estradiol—Alopecia—Docetaxel—skin cancer	0.000273	0.00115	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Temozolomide—skin cancer	0.000272	0.00115	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Docetaxel—skin cancer	0.00027	0.00114	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Temozolomide—skin cancer	0.000269	0.00114	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Docetaxel—skin cancer	0.000268	0.00114	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Dactinomycin—skin cancer	0.000268	0.00114	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000262	0.00111	CcSEcCtD
Ethinyl Estradiol—Urticaria—Temozolomide—skin cancer	0.000262	0.00111	CcSEcCtD
Ethinyl Estradiol—Asthenia—Dactinomycin—skin cancer	0.000261	0.00111	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Temozolomide—skin cancer	0.00026	0.0011	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Temozolomide—skin cancer	0.00026	0.0011	CcSEcCtD
Ethinyl Estradiol—Back pain—Docetaxel—skin cancer	0.00026	0.0011	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Docetaxel—skin cancer	0.000258	0.00109	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Fluorouracil—skin cancer	0.00025	0.00106	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Dactinomycin—skin cancer	0.000249	0.00106	CcSEcCtD
Ethinyl Estradiol—Vomiting—Bleomycin—skin cancer	0.000248	0.00105	CcSEcCtD
Ethinyl Estradiol—ABCB1—mammalian vulva—skin cancer	0.000247	0.00751	CbGeAlD
Ethinyl Estradiol—Rash—Bleomycin—skin cancer	0.000246	0.00104	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Bleomycin—skin cancer	0.000246	0.00104	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Temozolomide—skin cancer	0.000243	0.00103	CcSEcCtD
Ethinyl Estradiol—Urticaria—Fluorouracil—skin cancer	0.000241	0.00102	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Fluorouracil—skin cancer	0.00024	0.00102	CcSEcCtD
Ethinyl Estradiol—Asthenia—Temozolomide—skin cancer	0.000236	0.001	CcSEcCtD
Ethinyl Estradiol—Cough—Docetaxel—skin cancer	0.000234	0.000992	CcSEcCtD
Ethinyl Estradiol—Pruritus—Temozolomide—skin cancer	0.000233	0.000987	CcSEcCtD
Ethinyl Estradiol—Nausea—Bleomycin—skin cancer	0.000232	0.000983	CcSEcCtD
Ethinyl Estradiol—Vomiting—Dactinomycin—skin cancer	0.000232	0.000981	CcSEcCtD
Ethinyl Estradiol—Rash—Dactinomycin—skin cancer	0.00023	0.000973	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000227	0.000961	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Temozolomide—skin cancer	0.000225	0.000955	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Fluorouracil—skin cancer	0.000224	0.000947	CcSEcCtD
Ethinyl Estradiol—ABCB1—lymphoid tissue—skin cancer	0.00022	0.00667	CbGeAlD
Ethinyl Estradiol—Oedema—Docetaxel—skin cancer	0.000219	0.000928	CcSEcCtD
Ethinyl Estradiol—Dizziness—Temozolomide—skin cancer	0.000218	0.000923	CcSEcCtD
Ethinyl Estradiol—Infection—Docetaxel—skin cancer	0.000218	0.000922	CcSEcCtD
Ethinyl Estradiol—Nausea—Dactinomycin—skin cancer	0.000216	0.000917	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Docetaxel—skin cancer	0.000215	0.00091	CcSEcCtD
Ethinyl Estradiol—Pruritus—Fluorouracil—skin cancer	0.000215	0.00091	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Docetaxel—skin cancer	0.000213	0.000901	CcSEcCtD
Ethinyl Estradiol—ABCB1—female reproductive system—skin cancer	0.000212	0.00643	CbGeAlD
Ethinyl Estradiol—Vomiting—Temozolomide—skin cancer	0.000209	0.000887	CcSEcCtD
Ethinyl Estradiol—Rash—Temozolomide—skin cancer	0.000208	0.00088	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Fluorouracil—skin cancer	0.000208	0.00088	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Temozolomide—skin cancer	0.000208	0.000879	CcSEcCtD
Ethinyl Estradiol—Headache—Temozolomide—skin cancer	0.000206	0.000874	CcSEcCtD
Ethinyl Estradiol—Dizziness—Fluorouracil—skin cancer	0.000201	0.00085	CcSEcCtD
Ethinyl Estradiol—Nausea—Temozolomide—skin cancer	0.000196	0.000829	CcSEcCtD
Ethinyl Estradiol—Vomiting—Fluorouracil—skin cancer	0.000193	0.000818	CcSEcCtD
Ethinyl Estradiol—Rash—Fluorouracil—skin cancer	0.000191	0.000811	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Fluorouracil—skin cancer	0.000191	0.00081	CcSEcCtD
Ethinyl Estradiol—Headache—Fluorouracil—skin cancer	0.00019	0.000806	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000189	0.000801	CcSEcCtD
Ethinyl Estradiol—Fatigue—Docetaxel—skin cancer	0.000189	0.0008	CcSEcCtD
Ethinyl Estradiol—Constipation—Docetaxel—skin cancer	0.000187	0.000794	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Docetaxel—skin cancer	0.000181	0.000765	CcSEcCtD
Ethinyl Estradiol—Nausea—Fluorouracil—skin cancer	0.00018	0.000764	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Docetaxel—skin cancer	0.000179	0.000759	CcSEcCtD
Ethinyl Estradiol—ABCB1—head—skin cancer	0.000177	0.00538	CbGeAlD
Ethinyl Estradiol—Body temperature increased—Docetaxel—skin cancer	0.000173	0.000734	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Docetaxel—skin cancer	0.000173	0.000734	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Docetaxel—skin cancer	0.000161	0.000684	CcSEcCtD
Ethinyl Estradiol—Asthenia—Docetaxel—skin cancer	0.000157	0.000666	CcSEcCtD
Ethinyl Estradiol—Pruritus—Docetaxel—skin cancer	0.000155	0.000657	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Docetaxel—skin cancer	0.00015	0.000635	CcSEcCtD
Ethinyl Estradiol—Dizziness—Docetaxel—skin cancer	0.000145	0.000614	CcSEcCtD
Ethinyl Estradiol—Vomiting—Docetaxel—skin cancer	0.000139	0.00059	CcSEcCtD
Ethinyl Estradiol—Rash—Docetaxel—skin cancer	0.000138	0.000585	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Docetaxel—skin cancer	0.000138	0.000585	CcSEcCtD
Ethinyl Estradiol—Headache—Docetaxel—skin cancer	0.000137	0.000581	CcSEcCtD
Ethinyl Estradiol—Nausea—Docetaxel—skin cancer	0.00013	0.000551	CcSEcCtD
Ethinyl Estradiol—ABCB1—lymph node—skin cancer	0.000124	0.00376	CbGeAlD
